A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.
A double-blind trial of the effect of transfer factor on multiple sclerosis patients was carried out. In a series of fifty-six multiple sclerosis patients treated with monthly injections of either transfer factor or placebo for 1 year, no beneficial effect of transfer factor was noted. In addition,...
Main Authors: | Collins, R, Espinoza, L, Plank, C, Ebers, G, Rosenberg, R, Zabriskie, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1978
|
Similar Items
-
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial
by: Nosworthy, J, et al.
Published: (2001) -
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.
by: Noseworthy, J, et al.
Published: (1994) -
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article]
by: Noseworthy, J, et al.
Published: (2001) -
A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
by: Weinshenker, BG, et al.
Published: (1992) -
ACCEPTANCE OF PLACEBO-CONTROL TRIAL DESIGN BY PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS
by: Noseworthy, J, et al.
Published: (1989)